Prolexys Pharmaceuticals

Prolexys Pharmaceuticals is the proteomics subsidiary of Myriad Genetics.

History:

Formed as a joint venture among Myriad Genetics, Hitachi and Oracle in 2001. In 2003 they changed their name from Myriad Proteomics.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Other US

Research Focus:
Proteomics Disease Therapeutics-Research

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: